Centerspace (NYSE: CSR) (the “Company”) announced today its financial and operating results for the three and nine months ended September30, 2025. The tables below show Net Income (Loss), Funds from Operations (“FFO”)1, and Core FFO1, all on a per diluted share basis, for the three and nine months ended September30, 2025; Same-Store Revenues, Expenses, and […]

(NYSE:VNO), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) reported today: Quarter Ended September 30, 2025 Financial Results NET INCOME attributable to common shareholders for the quarter ended September 30, 2025 was $11,589,000, or $0.06 per diluted share, compared to net loss attributable to common shareholders of $19,154,000, or $0.10

(NYSE:UMH),(TASE:UMH),(TASE:UMH.TA), FREEHOLD, NJ, Nov. 03, 2025 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income for the quarter ended September 30, 2025 of $66.9 million as compared to $60.7 million for the quarter ended September 30, 2024, representing an increase of 10%. Net Income Attributable to Common Shareholders amounted to $4.2 million or

(NYSE:CBT), Fourth Quarter 2025 Diluted earnings per share (“EPS”) of $0.79 and Adjusted EPS of $1.70Fiscal Year 2025 Diluted EPS of $6.02 and Adjusted EPS of $7.25 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Cabot Corporation (NYSE: CBT) today announced results for its fourth quarter and fiscal year 2025. Fiscal Year Highlights Fiscal year Diluted

(NYSE:CBT), BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Cabot Corporation (NYSE: CBT) today announced that Robert Rist has been appointed Vice President of Investor Relations and Corporate Planning. The transition will take place over the course of the first quarter of fiscal year 2026. In this expanded role, Rist succeeds Steve Delahunt, who will continue

(NASDAQ:OLMA), SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences: Guggenheim 2nd Annual Healthcare Innovation

(NYSE:HII), NEWPORT NEWS, Va., Nov. 03, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that Tim Taylor has been appointed vice president of engineering, technology and design at its Newport News Shipbuilding division. Taylor, a U.S. Navy veteran, has served NNS for 29 years in positions of increasing responsibility, including work control, submarine ship's

(NYSE:PLX), PARMA, Italy and CARMIEL, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE American: PLX), have requested a re-examination of the recent negative opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency

(NasdaqGM:ANTA), SINGAPORE, Nov. 03, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (NASDAQ: ANTA) (“Antalpha” or the “Company”), a leading institutional digital asset financing platform, today announced that it will report its financial results for the third quarter of 2025 before the U.S. market open on November 10, 2025. The Company's management team will hold

(NASDAQ:XLO), WALTHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective November 1, 2025, the company granted a non-qualified stock option to purchase 5,700 shares of its common stock to one new employee